Evidence map›Paper›PMID 38808104›Full record

ArticleFrontiers in pediatrics2024

Genetic background of primary and familial HLH in Qatar: registry data and population study.

Elkhansa Elgaali, Massimo Mezzavilla, Ikhlak Ahmed, Mohammed Elanbari, Aesha Ali, Ghada Abdelaziz, Khalid A Fakhro, Ayman Saleh, Tawfeg Ben-Omran, Naima Almulla and 1 more

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Elkhansa ElgaaliPediatric Hematology and Oncology Department, Sidra Medicine, Doha, Qatar.
Massimo MezzavillaDepartment of Biology, University of Padua, Padua, Italy.
Ikhlak AhmedResearch Department, Sidra Medicine, Doha, Qatar.
Mohammed ElanbariResearch Department, Sidra Medicine, Doha, Qatar.
Aesha AliResearch Department, Sidra Medicine, Doha, Qatar.
Ghada AbdelazizDivision of Pediatrics, Sidra Medicine, Doha, Qatar.
Khalid A FakhroResearch Department, Sidra Medicine, Doha, Qatar.
Ayman SalehPediatric Hematology and Oncology Department, Sidra Medicine, Doha, Qatar.
Tawfeg Ben-OmranDivision of Genetic and Genomic Medicine, Sidra Medicine, Doha, Qatar.
Naima AlmullaPediatric Hematology and Oncology Department, Sidra Medicine, Doha, Qatar.
Chiara CugnoPediatric Hematology and Oncology Department, Sidra Medicine, Doha, Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Familial hemophagocytic lymphohistiocytosis (FHLH) is an inherited life-threatening disease. Five types are identified, with the addition of congenital immunodeficiency syndromes in which HLH is a typical manifestation. The literature on this disease is very scarce in the Middle East, with only a few scattered reports. Methods: We report detailed demographic, clinical, and genomic data from 28 patients diagnosed with primary and familial HLH over the last decade in Qatar. An evaluation was performed of allele frequencies of deleterious variants from 12 primary and familial HLH causative genes on the Qatar Genome Programme (QGP) cohort of 14,669 Qatari individuals. Results: The genetic diagnosis was obtained in 15 patients, and four novel mutations in Conclusions: We established the first primary and familial HLH Registry in the Gulf Region and identified novel possibly pathogenic variants present at higher frequency in the Qatari population, which could be used for screening purposes. Raising awareness about primary and familial HLH and implementing screening activities in the Qatari highly inbred population could stem into more comprehensive premarital and prenatal evaluations and faster diagnosis.

Indexed as

familial hemophagocytic lymphohistiocytosis (FHLH)geneticshemophagocytic lymphohistiocytosis (HLH)novel variantsQGP

Identifiers

PMID38808104
PMCPMC11130942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.